Students support Pfizer booster roll-out
Students support Pfizer booster roll-out
Following the FDA’s Sept. 22 approval of at-risk Americans to receive a Pfizer COVID-19 booster shot, over 60 million Americans became eligible to receive a third dose, according to NPR. At-risk groups include those 65 years and older, individuals 49-64 with medical conditions that put them at greater risk for the disease, and people working in high-risk settings such as schools and hospitals.
Although the booster has only been approved for groups who received the Pfizer shot, the FDA is slated to meet next week to review data regarding boosters for those who took the Moderna and Johnson & Johnson shots. Students have voiced their support for the rollout of boosters for vulnerable groups, and some said they hope in the coming months a third dose will become available to the general public.
The interviews and photos below were collected by Cross-Media News Writing students on-campus during the first week of October to gauge student reaction to the rollout of booster shots and what this means for the ongoing pandemic.